ALFA FinderNSE filing, NSE: SHRIAHIMSA. Summary written from the filing by ALFA Finder's alert engine.
Shri Ahimsa Naturals Ltd: key numbers
- Share price
- ₹403.00
- Market cap
- ₹988.1 Cr
- Revenue (annual)
- ₹123.3 Cr
- Net profit (annual)
- ₹29.11 Cr
- P/E (TTM)
- 34.0×Sector 25.4×
- Promoter holding
- 65.87%
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shri Ahimsa Naturals Ltd
All →Shri Ahimsa Naturals Results Update
Shri Ahimsa Naturals reported H1 FY27 revenue of ₹80 Crore, up 32%, and PAT of ₹16 Crore. Greenfield plant completion is expected by March 2027.
Shri Ahimsa Naturals H1 FY27 Results: Net Profit ₹15.8 Cr, Up 9.0% YoY
Shri Ahimsa Naturals Ltd reported revenue from operations of ₹80.1 Cr (+32.4% YoY) and net profit of ₹15.8 Cr (+9.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹15.8 Cr · +9.0% YoY
Shri Ahimsa Naturals Other Announcement
Shri Ahimsa Naturals filed a non-applicability certificate for the Q2 FY27 Corporate Governance Report. The SME-listed company invokes Reg 15 exemption, requiring no governance submission.
Shri Ahimsa Naturals Convertible Warrants
Shri Ahimsa Naturals Limited allotted 7.10 lakh equity shares following the conversion of warrants. The company received Rs. 12.09 Crore as the balance exercise price.
- Value
- ₹12.09 Cr
Shri Ahimsa Naturals Convertible Warrants
Shri Ahimsa Naturals Ltd. allotted 7,10,400 equity shares upon conversion of warrants at ₹227 per share. The total consideration for this conversion is ₹16.13 Crore.
- Value
- ₹16.13 Cr
Shri Ahimsa Naturals Annual General Meeting
Shri Ahimsa Naturals Limited concluded its 36th Annual General Meeting on September 14, 2026. Shareholders transacted business regarding financial statements, director re-appointment, and auditor remuneration.
Other other announcement announcements
All →RHI Magnesita India Other Announcement
RHI Magnesita India announced Abhishek Bajaj's appointment as CFO and Chief Investor Relations Officer, effective January 1, 2027. He is a chartered accountant with two decades' experience.
Shivchem Agro Other Announcement
Shivchem Agro Limited told BSE that its Reg 32 statement of deviation on IPO proceeds is not applicable for the half year ended September 30, 2026. The company's equity shares listed on the BSE SME Platform on October 6, 2026.
Ikoma Technologies Other Announcement
Ikoma Technologies will miss the November 14, 2026 deadline for Q2 and half-year unaudited results. It will convene a board meeting at the earliest possible date.
Orchid Pharma Other Announcement
Orchid Pharma's QIP monitoring report for the quarter ended September 2026 shows no deviation from objects. It flags revised fund allocation and delayed Jammu facility commercial operations.
Manipal Health Enterprises Other Announcement
Manipal Health Enterprises submitted CARE Ratings' monitoring agency report for the quarter ended September 30, 2026. It reports nil deviation from the IPO objects.
Apana Logistics Other Announcement
Apana Logistics filed its Reg 32 statement of IPO fund utilisation for the quarter ended 30 September 2026. No deviation or variation in utilisation was reported.